The Association of COVID-19 Degree on Transamination and Bilirubin Levels of COVID-19 Patients in RSUD Dr. Saiful Anwar Malang
DOI:
https://doi.org/10.21776/ub.crjim.2022.003.02.2Keywords:
COVID-19, bilirubin, transaminaseAbstract
Background : Corona virus 2019 (COVID-19) is an infectious viral disease caused by SARS-CoV-2 that has infected the world. COVID-19 can cause abnormalities which are characterized by increased levels of the enzyme transaminase and bilirubin. Research on the association between transaminase enzymes and bilirubin is still limited, further research is needed on the association between the degree of COVID-19 and levels of the transaminases and bilirubin enzymes.
Aim: To determine the association between liver function on the degree of severity and outcome of COVID-19 patients.
Method: This was the cross-sectional study. Sampling method was using consecutive sampling at RSUD Dr. Saiful Anwar Malangwho was treated from June 1st 2021 until November 31st 2021 by the Department of Internal Medicine. Statistical analysis used the Kruskal Walllis and Mann Whitney test with a significance level of p<0.5% and correlation analysis using Spearman.
Result: Among 90 patients included in this study there was a strong positive correlation between the degree of COVID-19 and levels of SGOT (r=0.954, p <0.001) and SGPT (r=0.727, p <0.001) and according to regression test, SGOT has the positive correlation towards degree of COVID-19 severity (p=0.026 CI95%: 0.002-0.028). There was a correlation between the degree of COVID-19 and the total bilirubin level (r=0.586, p=0.011). There was no correlation between levels of transaminase enzymes, total bilirubin, direct and indirect bilirubin on the patient's outcome (p>0.050).
Conclusion: There is a positive correlation between the degree of COVID-19 with levels of the enzyme transaminases, indirect and total bilirubin.
References
Cascella, Marco, Michael Rajnik, Abdul Aleem, Scott C, Dulebohn, Raffaela di Napoli. Features, Evalua-tion and Treatment of Coronavirus (COVID-19). 2021
Xu, X., Chen, P., Wang, J., Feng, J., Zhou, H., Li, X., Zhong, W., & Hao, P. Evolution of the novel coro-navirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Science China. Life sciences, 63(3), 457–460. 2020.
Kemenkes. Peta sebaran COVID-19. cited on 5 Jan-uari 2022. Available from: https://covid19.go.id/peta-sebaran. 2021
Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., Zhang, Y., Deng, W., Bao, L., Zhang, B., Liu, G., Wang, Z., Chappell, M., Liu, Y., Zheng, D., Leibbrandt, A., Wada, T., Slutsky, A. S., … Penninger, J. . A crucial role of angiotensin con-verting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nature medicine, (2005). 11(8), 875–879.
Zhang, C., Shi, L., & Wang, F. S. Liver injury in COVID-19: management and challenges. The lancet. Gas-troenterology & hepatology. (2020). 5(5), 428–430.
Wu, Y., Li, H., Guo, X., Yoshida, E. M., Mendez-Sanchez, N., Levi Sandri, G. B., Teschke, R., Ro-meiro, F. G., Shukla, A., & Qi, X. Incidence, risk fac-tors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis. Hepatology international, (2020). 14(5), 621–637.
Kumar-M, P., Mishra, S., Jha, D. K., Shukla, J., Choudhury, A., Mohindra, R., Mandavdhare, H. S., Dutta, U., & Sharma, V. (2020). Coronavirus disease (COVID-19) and the liver: a comprehensive system-atic review and meta-analysis. Hepatology interna-tional, (2020). 14(5), 711–722.
Wang, F., Yang, Y., Dong, K., Yan, Y., Zhang, S., Ren, H., Yu, X., & Shi, X. CLINICAL CHARACTERISTICS OF 28 PATIENTS WITH DIABETES AND COVID-19 IN WU-HAN, CHINA. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, (2020). 26(6), 668–674.
Liu, Z., Li, J., Long, W., Zeng, W., Gao, R., Zeng, G., Chen, D., Wang, S., Li, Q., Hu, D., Guo, L., Li, Z., & Wu, X. Bilirubin Levels as Potential Indicators of Disease Severity in Coronavirus Disease Patients: A Retro-spective Cohort Study. Frontiers in medicine. 2020. 7.
Xu, W., Huang, C., Fei, L., Li, Q., & Chen, L. Dynamic Changes in Liver Function Tests and Their Correla-tion with Illness Severity and Mortality in Patients with COVID-19: A Retrospective Cohort Study. Clin-ical interventions in aging, (2021). 16, 675–685.
Cai, Q., Huang, D., Yu, H., Zhu, Z., Xia, Z., Su, Y., et al. COVID-19: Abnormal Liver Function Tests. J. Hepa-tol. (2020).73 (3),
Ali N. Association Between COVID-19 Infection and Liver Injury: A Review of Recent Data. Frontiers in medicine, 7, (2020). 458.
Bertolini, A., van de Peppel, I. P., Bodewes, F., Moshage, H., Fantin, A., Farinati, F., Fiorotto, R., Jonker, J. W., Strazzabosco, M., Verkade, H. J., & Pe-serico, G. Abnormal Liver Function Tests in Patients With COVID-19: Relevance and Potential Pathogen-esis. Hepatology (Baltimore, Md.), 72(5), (2020). 1864–1872
Li, J., & Fan, J. G. Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease. Journal of clinical and translational hepatology, (2020). 8(1), 13–17.
Kavoliuniene, A., Vaitiekiene, A., & Cesnaite, G. Congestive hepatopathy and hypoxic hepatitis in heart failure: a cardiologist's point of view. Interna-tional journal of cardiology, (2013) 166(3), 554–558.
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei, Y., Wu, W., Xie, X., Yin, W., Li, H., Liu, M., Xiao, Y., … Cao, B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lan-cet (London, England). (2020). 395(10223), 497–506.
Benedé-Ubieto, R., Estévez-Vázquez, O., Flores-Perojo, V., Macías-Rodríguez, R. U., Ruiz-Margáin, A., Martínez-Naves, E., Regueiro, J. R., Ávila, M. A., Trautwein, C., Bañares, R., Bosch, J., Cubero, F. J., & Nevzorova, Y. A. Abnormal Liver Function Test in Patients Infected with Coronavirus (SARS-CoV-2): A Retrospective Single-Center Study from Spain. Journal of clinical medicine, (2021).10(5), 1039.
Cai, Q., Huang, D., Yu, H., Zhu, Z., Xia, Z., Su, Y., Li, Z., Zhou, G., Gou, J., Qu, J., Sun, Y., Liu, Y., He, Q., Chen, J., Liu, L., & Xu, L. COVID-19: Abnormal liver function tests. Journal of hepatology, (2020). 73(3), 566–574.
Nardo, A. D., Schneeweiss-Gleixner, M., Bakail, M., Dixon, E. D., Lax, S. F., & Trauner, M. Pathophysio-logical mechanisms of liver injury in COVID-19. Liv-er international : official journal of the Internation-al Association for the Study of the Liver, (2021). 41(1), 20–32.
Paliogiannis, P., & Zinellu, A. Bilirubin levels in pa-tients with mild and severe Covid-19: A pooled analysis. Liver international : official journal of the International Association for the Study of the Liver, (2020). 40(7)
Zhao YM, Shang YM, Song WB, et Al. Follow-up study of the pulmonary function and related phys-iological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. (2020). 25:100463
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Clinical and Research Journal in Internal Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
The copyright of the received article shall be assigned to the journal as the publisher of the journal. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.
